Hormonal supplementation in endocrine dysfunction in critically ill patients.

Journal Title: Pharmacological Reports - Year 2007, Vol 59, Issue 2

Abstract

One of the greatest challenges for a physician is a critically ill patient. Regardless of the reason for an admission to the Intensive Care Units (ICU) (e.g. myocardial infarction, severe pneumonia, trauma or many others) each of the above-mentioned conditions impairs homeostasis including instability of the endocrine system. The observed alterations in serum glucose level or clinical signs of hormonal imbalance alarm practitioners and prompt them to an intervention. However, side-effects of administered drugs have to be always considered, because every intervention in the endocrine system may have various consequences or prove itself maleficent. Since critical condition causes numerous changes in the hormonal system, the definition of endocrine gland failure in the ICU patients should differ from the definition related to the general population. This review is aimed at describing alterations, diagnosis and treatment options for an impaired carbohydrate metabolism and inadequate response of the adrenal and thyroid endocrine axis. It has been written in order to aid the choice between "the watch and wait strategy" and aggressive pharmacological intervention. Furthermore, several standard and innovative therapeutic procedures were described and, if possible, compared. Recent articles have been included in order to show current views on the up-to-date clinical approach.

Authors and Affiliations

Anna Duława, Łukasz Bułdak, Robert Krysiak, Bogusław Okopień

Keywords

Related Articles

Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers.

The compound MG-1(R,S), (1-[2-hydroxy-3(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one, and its enantiomers were tested for electrocardiographic, antiarrhythmic and hypotensive activities. The racemic mixture (MG-1(R,S)...

Endothelial dysfunction in pre-eclampsia.

The repeated demonstration of biomarkers of endothelial cell and leukocyte activation has suggested that the maternal syndrome of pre-eclampsia arises from a generalised maternal inflammatory systemic response incorporat...

Radiofrequency denervation with or without addition of pentoxifylline or methylprednisolone for chronic lumbar zygapophysial joint pain.

Radiofrequency neurolysis of lumbar medial branch is currently the only proven way to treat patients with chronic lumbar zygapophysial joint pain, however, in some patients it can cause transient postoperative pain due t...

Effect of cytochrome P450 (CYP) inducers on caffeine metabolism in the rat.

Our previous studies, carried out using rat cDNA-expressed cytochrome P450 (CYP) isoforms, liver microsomes and specific CYP inhibitors, showed that the 1-N- and 3-N-demethylation of caffeine at a therapeutic concentrati...

Behavioral effects of Bcl-2 deficiency: implications for affective disorders.

New hypotheses regarding affective disorders suggest a critical role for cellular resilience and plasticity. Bcl-2 is a central protein in these processes and is elevated by mood stabilizers and antidepressants. In previ...

Download PDF file
  • EP ID EP83878
  • DOI -
  • Views 84
  • Downloads 0

How To Cite

Anna Duława, Łukasz Bułdak, Robert Krysiak, Bogusław Okopień (2007). Hormonal supplementation in endocrine dysfunction in critically ill patients.. Pharmacological Reports, 59(2), 139-149. https://europub.co.uk/articles/-A-83878